Clinical Trial Update: A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing the effectiveness and safety of teriflunomide versus interferon beta-1a in relapsing multiple sclerosis, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)
• Teriflunomide (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-11-06